Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Cigna Group filings on SEC EDGAR ↗
The Cigna Group reported total revenues of $73.7 billion for the third quarter of 2026, a 6% increase year-over-year, driven primarily by pharmacy revenues. Shareholders' net income for the quarter was $1.4 billion, down from $1.9 billion in 2025, while nine-month net income remained relatively stable at $4.8 billion.
The Cigna Group reported third quarter 2026 total revenues of $73.7 billion, a 6% increase year-over-year, driven by growth in Evernorth Health Services and Cigna Healthcare. The company raised its full-year 2026 outlook for adjusted income from operations to at least $30.60 per share and announced a multi-year $3 billion modernization initiative called 'Accelerate to One'.
Term
3 months
“Our vision for The Cigna Group’s next chapter of profitable growth is grounded in delivering greater value and personalized experiences for our customers, with three priorities: driving core growth, leveraging our distinct capabilities, and executing with discipline. As we put our strategy in action, our strong third quarter results demonstrate how we are building on this momentum by making health care more affordable and personalized, while advancing Accelerate to One to drive productivity, reduce costs, and support sustained long-term earnings growth.”
Brian Evanko, President and Chief Executive Officer of The Cigna Group
Donna F. Zarcone informed the Board of Directors of The Cigna Group that she will retire from the Board effective December 31, 2026. The company stated that her retirement is not the result of any disagreement with the Company.
The Cigna Group is hosting its 2026 Investor Day to introduce its 'Lead to One' vision, focusing on personalization at scale and leadership in complex care. During the event, the company reaffirmed its full-year 2026 outlook and established a long-term average annual adjusted EPS growth target of 10-14% through 2030.